"Nitrosourea Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of compounds in which the core molecule is R-NO, where R is UREA.
| Descriptor ID |
D009607
|
| MeSH Number(s) |
D02.654.692 D02.948.594
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nitrosourea Compounds".
Below are MeSH descriptors whose meaning is more specific than "Nitrosourea Compounds".
This graph shows the total number of publications written about "Nitrosourea Compounds" by people in this website by year, and whether "Nitrosourea Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nitrosourea Compounds" by people in Profiles.
-
Hamre KM, Goldowitz D, Wilkinson S, Matthews DB. Screening for ENU-induced mutations in mice that result in aberrant ethanol-related phenotypes. Behav Neurosci. 2007 Aug; 121(4):665-78.
-
Creaven PJ, Cowens JW, Huben R, Petrelli N, Karakousis C, Traynor D. Phase I trial of a new nitrosourea, CGP 6809, given every 2 weeks. Cancer Chemother Pharmacol. 1989; 23(4):266-7.
-
Creaven PJ, Madajewicz S, Cowens JW, Plager JE, Pendyala L, Mittelman A, Petrelli N, Karakousis C, Huben R, Takita H, et al. Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809). Cancer Chemother Pharmacol. 1987; 20(1):37-40.
-
Mitchell EP, Killen JY, Smith FP, Willis LL, Schein PS, Woolley PV. Phase II study of PCNU in colorectal carcinoma. Cancer Treat Rep. 1981 Nov-Dec; 65(11-12):1129-30.
-
Hansen HH, Selawry OS, Pajak TF, Spurr CL, Falkson G, Brunner K, Cuttner J, Nissen NI, Holland JF. The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study. Cancer. 1981 Jan 01; 47(1):14-8.
-
Berd D, Wilson EJ, Bellet RE, Mastrangelo MJ. Effect of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea adjuvant therapy on the immune response of patients with malignant melanoma. Cancer Res. 1979 Nov; 39(11):4472-6.
-
Bellet RE, Catalano RB, Mastrangelo MJ, Berd D. Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea. Cancer Treat Rep. 1978 Dec; 62(12):2095-9.
-
Richards F, Pajak TF, Cooper MR, Spurr CL. Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer. Cancer Chemother Rep. 1973 Nov-Dec; 57(4):419-22.